OSTEOGENESIS IMPERFECTA
Clinical trials for OSTEOGENESIS IMPERFECTA explained in plain language.
Never miss a new study
Get alerted when new OSTEOGENESIS IMPERFECTA trials appear
Sign up with your email to follow new studies for OSTEOGENESIS IMPERFECTA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Researchers track safety of Bone-Strengthening drug in kids years after treatment
Disease control Not yet recruitingThis study aims to monitor the long-term safety of a drug called romosozumab in children and adolescents with osteogenesis imperfecta (brittle bone disease). It follows 71 young people who completed a previous treatment trial to check for any delayed side effects. The main goal i…
Matched conditions: OSTEOGENESIS IMPERFECTA
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for growing stronger bones: stem cell trial for fragile children
Disease control Not yet recruitingThis early-stage study is testing whether infusions of donor stem cells are safe and might help children with a severe form of brittle bone disease (osteogenesis imperfecta type 3). Researchers will give 12 children, aged 3 to 10, six stem cell infusions over two years to see if …
Matched conditions: OSTEOGENESIS IMPERFECTA
Phase: PHASE1, PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Mar 16, 2026 15:27 UTC
-
Hunt for hidden causes of childhood joint problems
Diagnosis Not yet recruitingThis study aims to find the most common causes of non-inflammatory joint problems in children at Assiut University Children's Hospital. Researchers will carefully examine 35 children with joint stiffness or deformity but no signs of typical joint inflammation. The goal is to impr…
Matched conditions: OSTEOGENESIS IMPERFECTA
Sponsor: Assiut University • Aim: Diagnosis
Last updated Mar 19, 2026 14:56 UTC